Arthur D. Little appoints Ulrica Sehlstedt to lead Global Healthcare & Life Sciences Practice
29.10.2019 12:38:00 EET | Business Wire | Press release
Arthur D. Little (ADL) today announced the appointment of Dr. Ulrica Sehlstedt as the new Global Practice Leader for its Global Healthcare & Life Sciences (HCLS) Practice.
With over 20 years of experience in the healthcare and life sciences sectors, Ulrica is a Partner based in ADL’s Stockholm office. She joined the company 13 years ago and has worked extensively for ADL clients across the healthcare and life sciences ecosystem; covering global industry players (pharma, medtech and biotech companies), healthcare providers (public and private), early stage life sciences companies and investors in the sector. Prior to joining ADL, she was CEO of a biotech start-up in molecular diagnostics and also has an extensive background in academic research.
ADL’s Global HCLS Practice works side-by-side with its clients to meet their challenges as the sector goes through an era of enormous medical and technological innovation, while delivering results in a more resource-constrained ecosystem. It achieves this through deep industry knowledge, combined with creative thinking. This enables ADL to work with its clients in harnessing innovation to overcome their most difficult strategic challenges.
Ulrica will take over from Nils Bohlin, who has successfully led the Global HCLS Practice for 8 years, nearly quadrupling its size. After a successful career of 37 years with ADL, Nils has reached retirement age, but will stay in close contact with the company in a new role as Senior Advisor.
Ignacio García Alves, Chairman and Chief Executive Officer at Arthur D. Little comments: “The healthcare and life sciences ecosystem is changing rapidly as innovation and digitalization radically disrupt the sector. At ADL we have already built a strong position in the market, and Ulrica’s leadership will drive further growth in the Global Healthcare & Life Sciences Practice, thanks to her wide experience, deep understanding and commitment to innovation.”
Dr. Ulrica Sehlstedt, Global Practice Leader, Global Healthcare & Life Sciences Practice at Arthur D. Little adds: “While innovation has always been central to healthcare, we are seeing unprecedented change as advances accelerate across the sector. At the same time available resources have not kept pace, meaning that balancing innovation and outcomes requires strategic understanding and market knowledge. ADL’s Global Healthcare and Life Sciences Practice is already perfectly positioned to help our clients meet these challenges, and I look forward to leading the team as the industry transforms.”
Ulrica holds a PhD in biophysics from Stockholm University, as well as an MSc in Chemical Engineering from Chalmers University of Technology, Gothenburg, Sweden. She has also been a member of the Swedish Research Council’s Scientific Council for Medicine for six years, and is regularly engaged in expert roles for life science research and industry initiatives directed towards governments and policy makers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191029005489/en/
Contact information
Cate Bonthuys
Catalyst Comms
+44 7746 56773
cate@catalystcomms.co.uk
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
mimik Operationalizes Agentic AI on the AMD Ryzen™ AI Embedded X100 Series23.7.2026 21:30:00 EEST | Press release
mimik today announced mimOE™ Embedded Edition, a package of its Agentix Operating Engine and a set of purpose-built tools for the AMD Ryzen™ AI Embedded X100 Series processor, the newest processor in a family designed for physical AI, autonomous systems, and industrial automation. Available to download today, mimOE Embedded Edition gives OEMs, tier-1 suppliers, system integrators, and agent developers the path to operationalize Agentix-Native systems (aka Agentic AI), in which autonomous agents can reason, coordinate, and act directly on devices, from PoC to scaled operations with certainty. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260723555565/en/ Agentic AI operations are both CPU and GPU bound. Enterprises can now scale with certainty. Generative AI has centered on the GPU. Agentix-Native systems must spread the work. In a real multi-agent workflow traced by mimik, more than 80 percent of operations were CPU work: d
U.S. Federal Court Permanently Bans 19 Online Sellers of Fake Urolithin A Supplements and Awards $5.3 Million in Damages to Timeline23.7.2026 17:27:00 EEST | Press release
Timeline (Amazentis SA), the Swiss life-sciences company that pioneered the postbiotic ingredient Urolithin A and its branded form Mitopure®, together with its U.S. subsidiary Timeline Longevity, Inc., announced today that the U.S. District Court for the District of Massachusetts has granted the companies’ motion for default judgments and permanent injunctions against 19 online sellers found to have marketed and sold nutritional supplements falsely advertised as containing Urolithin A. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722951066/en/ Timeline longevity supplement powered by Mitopure; proprietary, highly pure Urolithin A. The order, entered July 15, 2026 by Judge Myong J. Joun in Amazentis SA et al. v. The Partnerships and Unincorporated Associations Identified on Schedule “A”, Case No. 1:25-cv-12913-MJJ (District of Massachusetts), permanently enjoins 19 defaulting defendants from further manufacturing, market
TestMu AI Introduces the Source-to-Verdict Loop in Kane CLI, Carrying Every Requirement to a Ship Decision With Portable Proof23.7.2026 16:45:00 EEST | Press release
TestMu AI (formerly LambdaTest), the world's first Agentic AI-powered Quality Engineering platform, introduced a source-to-verdict loop in Kane CLI, its natural-language testing tool. Building on Kane CLI's evolution from a browser automation tool, the loop carries a product requirement to a ship decision, writing the tests, running them in the local browser, collecting the proof, measuring coverage from what actually happened, and returning a verdict. As AI agents write, run, and fix tests, a green checkmark is no longer enough: a step that checks nothing passes, a test written against a spec that changed weeks ago passes, and an agent that says “done” without the click ever landing passes. Empty green and earned green are the same color on every dashboard, the number climbs while the risk does not move. Kane CLI closes that gap: it carries a requirement to a verdict, and proves every step of it. One loop. Source to verdict. You no longer hand Kane CLI a test script, you hand it your
Norway’s health system adopts Wolters Kluwer UpToDate Enterprise Edition23.7.2026 16:30:00 EEST | Press release
Wolters Kluwer Health announced that Norway’s health system has renewed its adoption of UpToDate Enterprise Edition, a market-leading Clinical Decision Support (CDS) solution, for its nationwide health system which includes over 50 public hospitals and 11,000 beds in over 20 trusts. This extends a 15 year partnership with Helsebiblioteket, now part of the Norwegian Institute of Public Health (NIPH). Helping clinicians on a national scale Kjell Tjensvoll, Team Leader for Helsebiblioteket said, ‘‘Providing frontline teams with easy access to the latest medical knowledge is vital in reducing unwarranted variation and improving patient care on a national scale. UpToDate Enterprise Edition enables this, and we are delighted to strengthen our relationship with Wolters Kluwer and provide continued support for clinicians across the country.’’ UpToDate Enterprise Edition was selected by Helsebiblioteket, the Norwegian Electronic Health Library. The selection followed a competitive process by th
Boyd Watterson Global Names John Creswell Global Chief Client Officer to Accelerate Global Growth and Client Engagement23.7.2026 16:00:00 EEST | Press release
Boyd Watterson Global today announced the appointment of John Creswell as Global Chief Client Officer, a newly created senior leadership role that reflects the firm's continued investment in growth and its evolution into a leading global alternatives investment platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722823117/en/ John Creswell has joined Boyd Watterson Global as Global Chief Client Officer, a newly created role overseeing global sales, client engagement and marketing across the U.S., Europe and APAC. In this role, Creswell will oversee global sales, client engagement and marketing efforts across the United States, Europe and APAC, helping investors access the firm's capabilities while strengthening relationships with institutional and private capital partners worldwide. While based in Chicago, John will spend considerable time at the firm’s headquarters in Cleveland as well as in key offices globally. Cr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom